WegovyFolsom, CA

Wegovy in Folsom, CA

In the Pacific region, limited pharmacy competition and distribution costs can affect medication pricing. Wegovy® (Semaglutide, Injectable pen) by Novo Nordisk has been FDA-approved since 2021 for Chronic weight management. Weight Method offers a separate option for Folsom residents: licensed California providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program is priced at $199/month — same pricing regardless of location.

FDA-approved Wegovy prescribed by licensed providers. Delivered to your door.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Folsom is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated May 2026Medically reviewed by licensed providers

Wegovy in Folsom, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Wegovy to patients in Folsom from $199/month with virtual consultations and direct-to-door shipping.

How does this medication work for weight loss?

Semaglutide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Novo Nordisk developed Wegovy® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2021. Weight Method is a separate program: licensed providers in California evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for eligible Folsom, CA residents starts at $199/month.

What treatment options are available locally?

Hispanic adults in Folsom face disproportionately high rates of obesity and type 2 diabetes — conditions that Semaglutide therapy is studied for. Weight Method removes barriers that have historically limited access: our platform is fully bilingual, and our compounded Semaglutide program (dispensed by a U.S.-licensed 503A pharmacy; compounded Semaglutide is not FDA-approved) starts at $199/month with no insurance needed. Everything happens virtually from your Folsom home.

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

No. Weight Method operates on a direct-pay model with transparent pricing. The compounded Semaglutide program starts at $199/month and covers your medication, provider consultations, and free delivery to Folsom. No insurance claims, no prior authorizations, and no surprise bills. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.

Wegovy® is a Injectable pen manufactured by Novo Nordisk, FDA-approved since 2021 for Chronic weight management. It contains Semaglutide, which mimics natural incretin hormones to reduce appetite, slow gastric emptying, and help your body regulate hunger. Wegovy® is taken Once weekly. Weight Method does not sell Wegovy®; we are a separate program that prescribes compounded Semaglutide (dispensed by a U.S.-licensed 503A pharmacy and not FDA-approved) starting at $199/month.

Yes. Weight Method's licensed providers in California can prescribe compounded Semaglutide through a fully virtual process. You complete an online health assessment, have a virtual consultation, and if approved, your compounded Semaglutide is shipped directly to your Folsom address. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. There is no need to visit a physical clinic, and the program starts at $199/month.

Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk. Weight Method prescribes compounded Semaglutide, which is prepared by a U.S.-licensed 503A compounding pharmacy under state and federal pharmacy regulations. Compounded Semaglutide is not FDA-approved and is a different regulatory category from FDA-approved finished drug products. Your Weight Method provider will discuss whether compounded Semaglutide is an appropriate option based on your medical history.

Weight Method's compounded Semaglutide program starts at $199/month in Folsom. That price includes the medication, licensed provider consultations, and free home delivery. We don't bill insurance — there are no copays, no prior authorizations, and no surprise charges. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. Wegovy® is a separate FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk; its retail price varies by pharmacy.

Start Your Treatment

Consult with a licensed provider in California and start Wegovy from $199/month.

Get Started Now

Free consultation. No commitment.

Other Brands in Folsom

Nearby Cities

See More